Understanding why fewer women, especially Black and Hispanic, use HIV prevention methods

Gaps and Determinants in PrEP Uptake and Need: Understanding Disparities in PrEP Among Women in the United States

NIH-funded research Emory University · NIH-10896940

This study is looking into why fewer women, especially Black and Hispanic women, are using a medication called PrEP that helps prevent HIV, and it aims to find ways to make it easier for them to access and understand this important option for their health.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionEmory University NIH-funded
Lab location1 site (Atlanta, United States)
Project IDNIH-10896940 on NIH RePORTER

What this research studies

This research investigates the reasons behind the low uptake of pre-exposure prophylaxis (PrEP) among women in the United States, particularly focusing on Black and Hispanic women who are disproportionately affected by HIV. The study will analyze the characteristics of women's partnerships that indicate a need for PrEP, including factors that may not be recognized by the women or their healthcare providers. Additionally, it will improve the understanding of racial and ethnic disparities in PrEP usage by completing incomplete data on race/ethnicity in existing datasets and examining patterns of PrEP uptake across different regions. By addressing these gaps, the research aims to enhance awareness and accessibility of PrEP for women at risk of HIV.

Who could benefit from this research

Good fit: Ideal candidates for this research include women, especially Black and Hispanic women, who are at risk for HIV and may benefit from PrEP.

Not a fit: Patients who are not at risk for HIV or who do not identify as women may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved access to HIV prevention methods for women, particularly those from marginalized communities.

How similar studies have performed: Previous research has shown success in addressing disparities in healthcare access, suggesting that this approach could yield valuable insights and improvements.

Where this research is happening

Atlanta, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.